Bacteria sustain an infection by acquiring nutrients from the host to support replication. The host sequesters these nutrients as a growth-restricting strategy, a concept termed "nutritional immunity." Historically, the study of nutritional immunity has centered on iron uptake because many bacteria target hemoglobin, an abundant circulating protein, as an iron source. Left unresolved are the mechanisms that bacteria use to attain other nutrients from host sources, including amino acids. We employed a novel medium designed to mimic the chemical composition of human serum, and we show here that Bacillus anthracis, the causative agent of anthrax disease, proteolyzes human hemoglobin to liberate essential amino acids which enhance its growth. This property can be traced to the actions of InhA1, a secreted metalloprotease, and extends to at least three other serum proteins, including serum albumin. The results suggest that we must also consider proteolysis of key host proteins to be a way for bacterial pathogens to attain essential nutrients, and we provide an experimental framework to determine the host and bacterial factors involved in this process.
T
here are three broad, necessary, and common elements inherent in most if not all bacterial infections of vertebrate hosts. They are (i) the initial entry of the bacterial invader and adherence to host tissues, (ii) the production of virulence factors or toxins (usually proteins) that subvert host innate and acquired immune defense mechanisms, and (iii) the acquisition and construction of biomolecules to drive cellular metabolism for the production of progeny. There has been intense investigation, and knowledge of the biochemistry, cell biology, and contribution to disease of a diverse array of bacterial adhesins and virulence factors (points i and ii identified above) is growing. However, our knowledge of nutrient acquisition during pathogenesis has lagged, perhaps because it is viewed as being a necessary and somewhat mundane process that may lack the elegant sophistication observed with virulence factors. Considering that all systemic infections are absolutely dependent on the replication of bacterial cells, identifying the mechanisms by which bacteria might obtain essential nutrients during invasive disease may reveal new opportunities for drug development, as well as expand our knowledge of the many ways that bacteria subvert host defense systems.
Bacterial transport and synthesis of amino acids serve an important physiological function. In addition to their obvious role as the building blocks for proteins, amino acids also serve as inducers of cellular signaling, regulators of gene expression, and a source of energy (1, 2) . The biosynthetic pathways (pathways for the biosynthesis of genes, enzymes, and regulatory factors) of all 20 amino acids are well established in several bacterial species, with Escherichia coli being the model species for most of these studies (3) . It is also well-known that bacteria display defined auxotrophies for certain amino acids and thus require their uptake from the environment (4, 5) . This leads to an obvious but unaddressed question: what are the potential sources of these amino acids, and how might they be obtained?
When considering the sources of nutrients during disseminated infections, blood is a good candidate. Containing at any one time upwards of 600 distinct metabolites, including all 20 amino acids, mammalian blood itself can be considered a cupboard of important nutrients (6) . However, the acquisition of these nutrients is not straightforward. The low concentration of nutrients in serum and the widely variable nutrient levels associated with different physiological states and different individuals, coupled with the highly efficient host mechanisms designed to keep key nutrients sequestered (termed "nutritional immunity"), make the use of this cupboard difficult. Overcoming nutritional immunity has been proposed to be a mechanism leading to virulence, termed "nutritional virulence" (7) . Hypothesizing that pathogenic bacteria use the raw materials in blood to sustain a dramatic rate of replication, we sought to investigate the most basic requirements for bacterial growth under conditions that the investigator can control. We employed Bacillus anthracis, the causative agent of anthrax, as a model bacterium to investigate growth in blood-like environments, and we report the novel observation that host serum proteins, in particular, the oxygen carrier protein hemoglobin, can satisfy a growth-restricting amino acid auxotrophy. The mechanism by which this process occurs is through hemoglobin proteolysis, a finding that extends to the use of other serum proteins and involves the InhA1 protease. Inhibition of bacterial nutrient uptake mechanisms represents a novel entry point for new anti-infectives, and work presented here takes an important step toward revealing their function.
MATERIALS AND METHODS

Blood serum mimic (BSM).
Amino acid stocks were first prepared by dissolving the following in water at room temperature to the indicated final concentrations: alanine, 1,000 mM; arginine, 1,000 mM; asparagine, 100 mM; aspartic acid, 50 mM; glutamic acid, 50 mM; glutamine, 300 mM; glycine, 1,000 mM; histidine, 250 mM; isoleucine, 300 mM; leucine, 150 mM; lysine, 1,000 mM; methionine, 200 mM; phenylalanine, 150 mM; proline, 1,000 mM; serine, 1,000 mM; threonine, 500 mM; tryptophan, 50 mM; and valine, 500 mM. Separate stocks of cystine (1 M) and tyrosine (250 mM) were dissolved in 2.88 M and 1.2 M HCl, respectively. All stocks were stored at Ϫ20°C.
The following stock solutions were solubilized in sterile water at room temperature at the following final concentrations: 5 M NaCl, 1 M CaCl 2 , 1 M MgCl 2 , 1 M ZnCl 2 , 1 M potassium phosphate buffer (500 ml, pH 7.4) containing 69.84 g of dibasic and 13.47 g of monobasic potassium phosphate, and 1 M glucose filter sterilized with a 0.45-m-pore-size polyethersulfone (PES) membrane (VWR). Working BSM (4ϫ) was prepared by combining in 500 ml of sterile water the following (all concentrations are final): 5 mM KPO 4 buffer, 140 mM NaCl, 2.4 mM CaCl 2 , 0.8 mM MgCl 2 , 14.6 M ZnCl 2 , 6 mM glucose, and amino acids (alanine, 1.48 mM; arginine, 0.156 mM; asparagine, 0.352 mM; aspartic acid, 0.012 mM; cystine, 0.192 mM; glutamic acid, 0.232 mM; glutamine, 2.08 mM; glycine, 1 mM; histidine, 0.292 mM; isoleucine, 0.284 mM; leucine, 0.472 mM; lysine, 0.740 mM; methionine, 0.092 mM; phenylalanine, 0.218 mM; proline, 0.94 mM; serine, 0.392 mM; threonine, 0.664 mM; tryptophan, 0.212 mM; tyrosine, 0.24 mM; valine, 0.92 mM). This solution was filter sterilized using a 0.45-m-pore-size PES membrane and stored at 4°C. It was noted that the addition of CaCl 2 and ZnCl 2 resulted in the precipitation of insoluble phosphates that were filtered out. Thus, it is difficult to discern the exact concentrations of calcium and zinc in this solution. The 4ϫ BSM preparation was used throughout the experiments because it supports greater growth than 1ϫ BSM and, as such, provides a dynamic range with which to assess amino acid acquisition. Variations of BSM (1ϫ and 0.5ϫ BSM) were prepared as described above using the appropriate fraction of amino acids; the buffer, glucose, and salt concentrations remained the same. The 4ϫ BSM preparation can be stored at 4°C for up to 3 months. Table S1 in the supplemental material displays the composition of BSM. The concentration of iron in 4ϫ BSM was determined to be 79.53 nM by inductively coupled plasma optical emission spectroscopy (ICP-OES) (see Table S2 in the supplemental material).
Culture conditions. Cultures were incubated at 37°C with shaking at 200 rpm in BSM, as indicated below, or in lysogeny broth (LB) or brain heart infusion (BHI) medium for mutant construction and propagation. The following antibiotics were added as appropriate: kanamycin (25 g/ ml), spectinomycin (100 g/ml for B. anthracis and 50 g/ml for E. coli), and erythromycin (5 g/ml for B. anthracis and 150 g/ml for E. coli).
Measuring bacterial growth. Overnight LB-grown cultures of isolated colonies were washed 3 times with BSM and then added to a fresh BSM culture (4 ml) to a starting optical density (OD) at 600 nm of 0.1 and grown at 37°C with shaking (250 rpm) in glass test tubes (16 by 100 mm). The OD (at 600 nm) was measured every 2 h using a DU 800 spectrophotometer (Beckman Coulter) with polystyrene cuvettes (path length, 1 cm). For the experiment whose results are presented in Fig. 2B , cultures were treated with a protease inhibitor cocktail tablet (complete mini EDTAfree tablets; Roche) according to the manufacturer's instructions. For the experiment whose results are presented in Fig. 2C , culture supernatants (50 ml) were collected by centrifuging a culture of B. anthracis Sterne 34F2 that had been incubated in the absence of valine (12 h) at 15,000 ϫ g for 10 min and then boiled at 100°C for 10 min. Treated supernatants (4 ml) were seeded with washed B. anthracis cells in 4ϫ BSM (minus valine, plus hemoglobin), and growth was recorded as described above. Apohemoglobin was prepared as previously described (8) . For the experiment whose results are presented in Fig. 2D , phosphoramidon and 1,10-phenanthroline were obtained from Sigma (catalog numbers R7385 and 131377, respectively). Phosphoramidon was reconstituted in sterile water to 10 mM and stored at Ϫ20°C. 1,10-Phenanthroline was dissolved in 100% acetone to 500 mM and stored at Ϫ20°C.
anthracis strains used were Sterne 34F2 containing pUTE657, a shuttle vector encoding a spectinomycin resistance cassette (9, 10); Sterne 7702 (11); ANR-1 (12); and Ames 35 (13) . B. anthracis UM23C1-2 (pXO1 negative [pXO1 Ϫ ], pXO2 Ϫ ) secA calY null was used to purify InhA1 (14) . E. coli TG-1 was the host for cloning. E. coli GM2163 (a dam dcm mutant) was used to generate unmethylated plasmid DNA for electroporation of B. anthracis (15, 16) .
Mutant construction. Null mutants of B. anthracis Ames 35 were described by Pomerantsev et al. (13) . Null mutants derived from Sterne 7702 and ANR-1 were created using allelic exchange or markerless gene deletion. The calY coding sequence in calY-null mutants UT356 (in Sterne 7702) and UT410 (in ANR-1) was replaced with an ⍀ spectinomycin resistance cassette using pUTE583, as described previously (17) .
Media. Iron-depleted medium (IDM) was prepared as previously described (18) , except that no chelation was performed, the concentration of glucose was increased to 10 mM, and Casamino Acids were excluded to create a completely defined medium. All other media were prepared according to the manufacturers' instructions: lysogeny broth (Life Technologies, Grand Island, NY), tryptic soy broth (TSB; Difco Laboratories, Detroit, MI), and brain heart infusion medium (Teknova, Hollister, CA).
Hemoglobin preparation. Oxyhemoglobin and CO-hemoglobin were prepared as described by Di Iorio (19) . Briefly, oxygen or carbon monoxide was bubbled through human methemoglobin (incubated in an ice bath) in the presence of strong light. The final preparations were dialyzed against 20 mM Tris, pH 8.0, and stored at Ϫ20°C. Methemoglobin was reconstituted in 20 mM Tris, pH 8.0, at 1 mM and stored at Ϫ20°C.
MS. B. anthracis was grown with or without hemoglobin for 16 h, and the supernatants were precipitated and resuspended as described above. The protein concentration was determined using a NanoOrange kit (Invitrogen Inc.), the protein concentrations in the samples were set to 0.01 g/l with 50 mM ammonium bicarbonate buffer (pH 7.9), and the samples were reduced with 100 mM dithiothreitol (DTT; Bio-Rad Inc.) on a rotary shaker at 800 rpm at room temperature for 30 min. Trypsin (40 ng; Sigma) and acetonitrile (final volume, 10%) were added, and the reaction mixtures were incubated at 37°C for 16 h with shaking (50 rpm). The digestion was stopped by the addition of formic acid to a 5% final volume, the samples were dried, and the digests were resuspended in a 0.1% formic acid and 5% acetonitrile solution. Approximately 200 ng of each sample was injected into an Eksigent nano-liquid chromatography (nano-LC) system controlled by Analyst software (version 1.6; AB Sciex Inc.). The peptides, which were trapped with a 200-m by 0.5-mm ChromXP C 18 -CL column (120 Å) and then with a 75-m by 15-cm ChromXP C 18 -CL column, were passaged at a flow rate of 3 l/min with 50% 0.1% formic acid and 50% acetonitrile for 5 min at 23°C, and the organic mobile phase was set at a 90-min gradient from 5 to 35% acetonitrile in 0.1% formic acid (flow rate, 300 nl/min). The Eksigent nano-LC was linked via a Nanoflex system to an AB Sciex triple time of flight (TOF) 5600 mass spectrometer (MS; the ionization voltage was set at 2,400 V), with MS precursor ions of from 400 to 1,250 atomic mass units being selected. The cycle time was 0.25 s, and the 40 most abundant ions were allowed to pass to the collision cell for ion production. MS/MS spectra were acquired at 0.1 s at the m/z range of 100 to 2,000. Raw WIFF files were fed into the Protein Pilot program (version 4.5; Paragon-based software from AB Sciex Inc.) for a database search (NCBI) using B. anthracis as the query.
Iron quantification. Concentrated samples (deionized [DI] water, DI water and glassware, and 4ϫ BSM) were boiled down in small beakers from 50 ml to a final volume of 5 ml. These samples, along with tap water, DI water (Milli-Q filtered), and LB (900 l each), were treated with 100 l 100% nitric acid and incubated at room temperature overnight. Each 1-ml sample was then diluted in 4 ml sterile DI water (total, 5 ml) and subjected to ICP-OES (Agilent ICP-OES 725) at the University of Houston. Five iron standards at concentrations of 0.05 ppm, 0.1 ppm, 0.5 ppm, 1 ppm, and 2 ppm were analyzed at the beginning and the end of each run to set up the calibration line. Online data reduction was conducted with Agilent ICP Expert II software. The analytical precision was better than 5%. The values reported for the original samples were calculated from the raw values by multiplying by the dilution and concentration factors reported above.
Serum collection, serum proteins, and synthetic peptides. Bovine serum was prepared from fresh bovine blood (Pel-Freez Biologicals, Rogers, AR), which had been treated with sodium heparin, by centrifugation with BD Vacutainer tubes (PST gel and lithium heparin tubes, 8 ml) according to the manufacturer's protocol and stored at 4°C for up to 1 week. Human hemoglobin, equine heart myoglobin, human transferrin, human fibrinogen, and bovine hemin were all obtained from Sigma (catalog numbers H7379, M1882, T3309, F3879, and H9039, respectively). Hemoglobin and myoglobin were reconstituted in 1ϫ phosphate-buffered saline to 1 mM and stored at Ϫ20°C. Transferrin was reconstituted in sterile water to 1 mM and stored at 4°C. Bovine hemin was solubilized to 1 mM in 10 mM NaOH. Mouse immunoglobulin G (IgG) was obtained from Innovative Research (catalog number IR-MS2-GF), reconstituted in sterile water to 1 mM, and stored at Ϫ20°C. These stocks were then diluted into medium at the concentrations indicated below. Fibrinogen was reconstituted directly into warmed (37°C) BSM and used immediately. Bovine serum albumin (BSA) was obtained from Fisher (catalog number BP1605) and added directly into the formulation of 4ϫ BSM. The peptides used in the experiment whose results are presented in Fig. 3 were custom-made by the Biomatik Company (Wilmington, DE), received as hydrochloric salts, diluted in sterile water to 5 mM, and stored at Ϫ20°C.
Analysis of hemoglobin by SDS-PAGE. B. anthracis cultures (1.5-ml samples) were centrifuged at 15,000 rpm for 10 min, 1 ml of supernatant was removed and added to 4 ml of 100% acetone, and the mixture was incubated at Ϫ20°C overnight. Samples were then centrifuged at 13,000 rpm for 30 min at 4°C, the supernatant was removed, and 5 ml of fresh 100% acetone was added before incubation at Ϫ20°C for 4 h (this process was repeated 2 times). The pellet was resuspended in 50 l of sterile water and mixed with 50 l complete sample buffer, and the mixture was boiled for 10 min and stored at Ϫ20°C. All SDS-polyacrylamide gels were 16% Tris-Gly (Jule, Milford, CT), 4 l of protein was loaded, and electrophoresis was performed at 35 mA for 50 min.
Purification of InhA1. InhA1 was purified using a previously described method (14) . InhA1 was expressed in B. anthracis strain UT357 cultured in LB medium for 16 h at 37°C. Filtered supernatant was concentrated approximately 50-fold using Amicon Ultra-15 Ultracel centrifugation filters with a 10-kDa size exclusion (Millipore, Darmstadt, Germany). Concentrated supernatant was dialyzed against buffer A (50 mM Tris, 50 mM NaCl, pH 8.0). After passage through a 0.22-m-pore-size surfactant-free cellulose acetate filter (Nalgene, Rochester, NY), the protein sample was fractionated by anion-exchange chromatography on a Mono Q 5/50 GL column (GE Healthcare). Proteins were eluted with a linear gradient of 50 mM to 1 M NaCl by using an Ätka purifier system. Fractions containing InhA1 were checked for purity by SDS-PAGE and Coomassie G-250 staining (0.125%) and were verified to contain InhA1 by Western blot analysis with a peptide antibody specific to InhA1. Fractions containing InhA1 were pooled and buffer exchanged into Tris-buffered saline (TBS; pH 7.4) using Amicon Ultra-15 centrifugation filters with a 10-kDa cutoff.
Proteolysis assay. Purified InhA1 was mixed with hemoglobin substrate (10 M) in TBS (pH 7.4) and incubated at 37°C from 0 to 6 h. The reactions were stopped using 5ϫ SDS sample buffer (50% glycerol, 8% DTT, 10% SDS, 200 mM Tris, pH 6.8), and the reaction mixtures were boiled for 10 min. Samples were separated by SDS-PAGE (15% polyacrylamide) and stained with Coomassie G-250 (0.125%). Recombinant protective antigen (rPA; BEI Resources, ATCC, Manassas, VA) was used as a positive control for protease activity. For the experiment whose results are presented in Fig. 4H , purified InhA1 or heat-inactivated protease (which had been boiled for 10 min) was mixed with hemoglobin substrate (10 M) and 1,10-phenanthroline (500 M) or acetone in 4ϫ BSM (pH 7.4) in 100-l reaction mixtures. and the mixture was incubated at 37°C for 12 h. Reactions were stopped using complete sample buffer, and the reaction mixtures were boiled for 10 min. Samples were separated by SDS-PAGE with 16% Tris-Gly polyacrylamide gels (Jule, Milford, CT) into which 15 l of the original reaction mixture was loaded, electrophoresis was performed at 35 mA for 50 min, and the gel was stained with Coomassie R-250.
RESULTS
Blood serum mimic for growth of bacterial pathogens. To test the hypothesis that blood proteins are a source of essential nutrients, it was first necessary to choose a suitable bacterial pathogen for these studies. We chose B. anthracis, a zoonotic pathogen that has attained notoriety for its risk and use in biowarfare, because (i) it attains very high levels of growth (as high as 10 9 CFU/ml of blood or tissue) in infected mammals (20) , (ii) there is a steady literature of nearly 80 years of knowledge on the growth of this bacterium under a wide range of conditions (21), (iii) its genome has been sequenced, and strategies to make knockouts are available (22) , and (iv) much is known about its secreted proteome (23, 24) .
We next considered what growth medium would be suitable to test this hypothesis. The results of a comparison of the mean circulating levels of amino acids in human serum to the concentration of amino acids in media commonly used to grow B. anthracis are shown in Fig. S1A in the supplemental material. Ristroph (a medium commonly used to enhance the expression of anthrax toxin), EZ Rich, and iron defined medium (IDM; a medium used to assess the iron requirements of B. anthracis [18] ) all contain levels of amino acids much higher than the mean circulating levels reported for a resting human (18, (25) (26) (27) . As such, it was decided to generate a medium that more accurately modeled the basic chemical and nutritional constituents of serum. Ideally, this medium would be defined, in the sense that the investigator could control the levels of every potential nutrient found in blood without having to worry about the potential inhibition of growth that arises from immunological factors found in serum, thereby allowing questions about the importance of any nutrient, once added under a controlled set of conditions, to be probed. The result was a medium that we termed blood serum mimic (BSM). BSM contains the mean circulating concentrations of amino acids, sugars, and salts for an adult human and is buffered at pH 7.4 (a list of components and their concentrations is presented in the Materials and Methods and Table S1 in the supplemental material) (27) . BSM lacks any hormones, proteins, xenobiotics (molecules acquired from ingestion, e.g., caffeine), cells, and immunological factors; however, as we will see here, such components can simply be added to the medium to determine how the growth or metabolism of the microbe in question responds to their presence.
Employing B. anthracis Sterne 34F2 (pXO1 ϩ , pXO2 Ϫ ), a strain lacking the plasmid carrying the operon for the biosynthesis of the polyglutamic acid capsule (10), we tested growth in BSM medium and compared it to that in defined media, such as Ristroph and IDM, and the rich but undefined media lysogeny broth (LB), brain heart infusion (BHI), and tryptic soy broth (TSB) (see Fig. S1B and C in the supplemental material). As expected, B. anthracis demonstrated lower levels of growth in BSM, which contains low concentrations of amino acids relative to the concentrations in both defined and rich media. This finding suggests that the concentrations of components typically found in serum are substantially growth restrictive, a finding that will allow one to test if the addition of different sources of nutrients enhances growth.
Having in hand a medium whose composition resembled the basic molecular composition of serum, which was restrictive but supported a certain level of growth for B. anthracis, we next used a dropout approach to determine which amino acids were absolutely necessary for B. anthracis replication. The amino acids valine and methionine, when omitted from BSM, prevented any increase in culture optical density, an effect not observed for the remaining 18 amino acids (see Fig. S2 in the supplemental material). These apparent auxotrophies for valine and methionine are consistent with the findings of previous studies (21, 28) . Interestingly, the Sterne genome contains all annotated genes necessary for the biosynthesis of these amino acids, which may indicate that the observed auxotrophies may be due to some other regulatory or postgenomic process. Nevertheless, this dropout approach gives us an experimental model system to test and identify serum components that may provide these amino acids under conditions of nutrient deprivation.
Hemoglobin rescues the valine auxotrophy. Having established the auxotrophies for valine and methionine in B. anthracis, we next sought to define the components of blood that would enhance the growth of this pathogen under these conditions. In this regard, we first considered whether blood proteins could be a source of these amino acids in BSM. There are many proteins found in blood, but one of the most abundant and important is hemoglobin, the iron-binding protein that oxygenates tissues (29) . Hemoglobin is also interesting because there is an extensive literature suggesting that this protein is a prominent source of iron for bacterial pathogens (through its bound heme iron cofactor) (30, 31) . This list includes the Gram-negative bacterial genera Pseudomonas, Neisseria, Yersinia, Haemophilus, Shigella, Vibrio, and Escherichia (32) . It also includes the Gram-positive bacterial genera Staphylococcus, Streptococcus, Listeria, and Bacillus, including B. anthracis (33) .
Hypothesizing that hemoglobin may also serve as a source of essential amino acids, we tested what would happen when it was added to BSM that lacks valine. Unexpectedly, addition of hemoglobin in a concentration-dependent manner provided the nearly complete (Fig. 1A) or partial (Fig. 1B) rescue of growth in BSM lacking valine or methionine. We reasoned that this rescue might be due to a beneficial effect provided by adding a source of heme iron to this medium. To investigate this, we first determined by inductively coupled plasma optical emission spectroscopy (ICP-OES) that the concentration of iron in 4ϫ BSM is 79.53 nM (see Table S2 in the supplemental material). Addition of an iron spike to deionized water with a known concentration of ferrous sulfate to yield a final concentration of 1 M produced the expected value, thereby demonstrating the sensitivity and accuracy of ICP-OES. The ϳ80 nM iron concentration in BSM was much lower than the iron levels found in LB but higher than those found in deionized water, suggesting that BSM may be a somewhat iron-restrictive environment. Interestingly, the hemoglobin rescue was not observed when two distinct sources of iron (ferrous sulfate and hemin) were added to valine-less BSM, and their addition resulted in little or no additional growth when added in the presence of hemoglobin ( Fig. 1C and D) . In fact, the addition of hemoglobin and heme had a slight growth reduction effect compared to the effect of hemoglobin alone on growth, perhaps indicative of heme toxicity (34) . These two findings suggest that the growth observed in this system may not be primarily driven by iron. Further support for this hypothesis comes from studies where hemoglobin was treated with mild acid to remove its bound heme (to obtain apohemoglobin), thereby eliminating the iron bound to this protein. As observed in Fig. 1E , apohemoglobin rescued the growth of bacilli in BSM lacking valine to a similar extent as heme-bound globin, a finding that suggests that the growth advantage provided by hemoglobin is not dependent on the heme iron bound to hemoglobin.
The hemoglobin reagent used in the studies described above was methemoglobin, where the iron is in the ferric (Fe 3ϩ ) state. This form, although readily commercially available, represents only about 1 to 2% of the total circulating hemoglobin in a human at any one time. To determine if oxyhemoglobin, the ferrous and dominant form observed in the circulation (35) , could also enhance the growth of B. anthracis in the absence of valine, we grew B. anthracis in BSM lacking valine in the presence or absence of both met-and oxyhemoglobin. As demonstrated in Fig. S3A in the supplemental material, oxyhemoglobin enhanced the growth of bacilli relative to the level of growth for the BSMonly control, albeit at lower levels than methemoglobin. Interestingly, hemoglobin bound to carbon monoxide (CO-hemoglobin) also enhanced growth, despite the fact that the CO-hemoglobin (as well as the oxyhemoglobin) versions of hemoglobin are known to be more resistant to degradation (36, 37) . All hemoglobins in this assay were confirmed to be in the expected oxidation state by absorbance spectroscopy (see Fig. S3C in the supplemental material). Taken together, these results suggest that hemoglobin can somehow overcome the auxotrophy for valine and methionine in B. anthracis under conditions where the concentrations of these amino acids are low or these amino acids are absent. Furthermore, this property appears to be independent of the well-known benefit normally provided by obtaining iron from the heme in hemoglobin, despite evidence that the bacilli grow better on these iron sources when BSM contains all 20 amino acids.
Hemoglobin is proteolyzed by B. anthracis. We aimed to determine the mechanism by which hemoglobin can overcome the growth restriction of B. anthracis in the absence of two critical amino acids. As shown in Fig. 2A , dialyzing the hemoglobin did not prevent the hemoglobin-dependent recovery of growth, indicating that this effect is not due to contaminating amino acids in the hemoglobin preparation. When the rescue experiment was performed in the presence of a broad-spectrum protease inhibitor cocktail, only a partial restoration of growth was observed (Fig.  2B) . The rescue was also delayed, and the maximal growth was inhibited if the spent supernatant from a B. anthracis culture grown in BSM (without valine) was boiled and then added to a fresh culture grown under identical conditions (Fig. 2C) . We also tested if the hemoglobin-dependent growth enhancement could be inhibited with two inhibitors, phosphoramidon and 1,10-phenanthroline, which were previously shown to differentially inhibit B. anthracis proteases (38) . Upon the addition of phosphoramidon to a culture of B. anthracis grown on hemoglobin, only a slight inhibition of growth was observed; in contrast, 1,10-phenanthroline completely inhibited the growth (Fig. 2D) . The sensitivity of this process to heat, dampening of the process in the presence of protease inhibitors, and acceleration of the process by bacillus culture supernatants suggested that hemoglobin is proteolyzed by B. anthracis and serves as a source of valine under conditions of nutrient deprivation. Furthermore, the complete inhibition by 1,10-phenanthroline indicates that a specific secreted protease may be involved in this process.
To more rigorously determine if, in fact, hemoglobin was being degraded, we used two distinct molecular methods to directly determine the fate of hemoglobin in these cultures. First, we grew B. anthracis in BSM in the absence of valine with or without hemoglobin and subjected an aliquot of the culture supernatant to SDS-PAGE. Hemoglobin, as expected, rescued the growth of bacilli in the absence of valine (Fig. 3A) and was substantially degraded compared to the level of degradation of the hemoglobin incubated for the same length of time only in BSM (Fig. 3B) . Of note, we also confirmed by SDS-PAGE that the methemoglobin and oxyhemoglobin from the assays whose results are presented in Fig. S3A in the supplemental material were proteolyzed (see Fig. S3B in the supplemental material). Second, we subjected the supernatant samples from the assays whose results are presented in Fig. 3A to matrix-assisted laser desorption ionization-time of flight tandem MS/MS to identify the extent of proteolysis of hemoglobin (for clarity, an outline of the work flow for this mass spectrometry experiment is provided in Fig. S4 in the supplemental material) . Interestingly, more than 15 distinct peptides pertaining to hemoglobin were detected per subunit, which, when considered in the context of cleavage by trypsin prior to mass spectrometry, allowed us to assemble a map of all the B. anthracis-specific cleavage sites (Fig. 3C) . Analysis of the cleavage sites revealed a propensity toward small, nonpolar amino acids (see Fig. S5 in the supplemental material). However, tandem MS/MS prevented us from quantitating the abundance of these putative peptides, as there are overlapping tryptic and B. anthracis-specific peptides being sequenced. To further test the hypothesis of hemoglobin proteolysis, one smaller peptide containing two valines from the ␣ chain of hemoglobin (93-RVDPVNFKL-101) was employed to test for a possible role of this peptide in relieving the valine auxotrophy. Indeed, a synthesized version of this peptide completely restored the growth of B. anthracis in BSM in the absence of valine, an effect that was not observed with an equivalent peptide with both valines replaced by alanine or the homologous valine-less peptide from the ␤ chain (Fig. 3D) . Taken together, these data suggest that B. anthracis can proteolyze hemoglobin to smaller peptides for the purpose of attaining critical amino acids. Considering that the tetramer of hemoglobin contains 62 valines to only 6 methionines (ϳ10 to 1 more valine than methionine), it would seem that hemoglobin serves as a source of both amino acids, especially valine, under conditions where these amino acids are low or lacking.
A secreted protease degrades hemoglobin. The preliminary data presented thus far invoke a protease(s) in the utilization of hemoglobin as an amino acid source. At least six proteases are secreted into the medium of B. anthracis cultures (9, 23, 24) . Two abundant members include InhA1 (immune inhibitor A1) and NprB (neutral protease B), which are metalloproteases that cleave extracellular matrix proteins, including fibrinogen, laminin, collagen, and ␣ 2 -macroglobulin (38) . InhA1 also cleaves prothrombin, which stimulates blood coagulation (39) . A summary of the known or putative proteases from B. anthracis is shown in Table  S3 in the supplemental material. To identify the protease responsible for this activity, we utilized B. anthracis strain Sterne 7702. This strain was chosen as the model strain for these studies be-cause it has been used to study the role of proteases in anthrax biology (9, 14) , there are well-characterized derivatives harboring isogenic deletions in some of the genes known to encode proteases, and protease mutants of this strain have previously been used to study anthrax pathogenesis (40) . We first determined if this strain could use hemoglobin as a source of valine, and indeed, growth was enhanced in BSM lacking valine (Fig. 4A) . We next tested two available isogenic mutants, one with a deletion of the gene for camelysin (⌬calY) and one with a deletion of the gene for InhA1(⌬inhA1), for their growth under equivalent conditions. Interestingly, whereas the ⌬calY strain showed wild-type levels of growth, the ⌬inhA1 strain was not able to be rescued by hemoglobin in BSM lacking valine (Fig. 4B and C) . Indeed, this phenotype was also observed for strains lacking inhA1 that were generated in two other B. anthracis strain backgrounds (strains ANR-1 [12] and Ames 35 [41] ) and was not observed in Ames 35 derivatives lacking nprB, tasA, and mmpZ (not shown). This is consistent with the results of our cleavage site analysis (see Fig. S5 in the supplemental material), as previous work demonstrated that an InhA1 homologue targeted nonpolar amino acids (42) . To validate if InhA1 is directly involved in this phenotype, we tested if purified InhA1 could directly proteolyze human hemoglobin. Indeed, mixing of InhA1 with hemoglobin and assessment of the state of hemoglobin by SDS-PAGE ( Fig. 4D ; the results are quantified in Fig. 4E ) demonstrated that approximately 50% of the hemoglobin is proteolyzed after 6 h. This proteolysis was inhibited by heating the InhA1 protease for 5 min at 100°C and by addition of 1,10-phenanthroline, the same inhibitor that prevented the rescue of hemoglobin (Fig. 2D) , to the reaction mixture (Fig. 4F) . Taken together, these genetic and biochemical data suggest that the im- B. anthracis uses other serum proteins as a source of valine when grown in BSM. Having identified that InhA1 proteolyzes a major serum protein (hemoglobin) to satisfy a nutritional requirement for valine, we wondered if this property also applied to other abundant and important circulating blood proteins. To BSM lacking valine, we added some common serum proteins at concentrations found in human blood (27) . The addition of bovine serum albumin and human transferrin dramatically improved the growth of B. anthracis in the absence of valine (Fig.  5A) . Albumin is noteworthy in this regard because it is the most abundant free serum protein and likely the most accessible during an actual infection. Fibrinogen, a protein important in the bloodclotting response, also enhanced the growth of B. anthracis in the absence of valine, but murine immunoglobulin G (IgG) did not afford any growth benefit. Surprisingly, no appreciable growth was observed in the presence of myoglobin (Mb), the muscle version of hemoglobin, when used at a physiological concentration (3.4 nM; not shown), or the molar equivalent to hemoglobin monomers (40 M). Furthermore, when serum protein concentrations were normalized on the basis of the primary amino acid sequence to contain an equimolar amount of valine, hemoglobin supported growth significantly faster than serum albumin and myoglobin (data not shown). The latter finding is noteworthy because hemoglobin and myoglobin are highly similar with respect to their tertiary structures, which suggests that the use of hemoglobin is a rather specific process. Figure S6 in the supplemental material confirms that serum albumin, hemoglobin, myoglobin, transferrin, and fibrinogen were all proteolyzed by B. anthracis in this experiment, with IgG seemingly being resistant to this process. These results were not strain dependent since similar proteolysis profiles were also observed for strain Sterne 34F2 (not shown). Expanding upon the hypothesis that serum proteins are an important amino acid source, we tested whether inhA1 was important for growth in bovine serum (Fig. 5B) . Although the inhA1 mutant grew just as well as the Sterne 7702 parent strain when free amino acids were present (4ϫ BSM), it exhibited a severe growth defect after 6 h in serum and was unable to reach the maximum optical density observed for the parent strain. This finding demonstrates the importance of InhA1 proteolysis to the attainment of high levels of bacterial replication in serum. Taken as a whole, these data suggest that several prominent serum proteins, including serum albumin and fibrinogen, but not circulating IgG can serve as a source of critical amino acids for B. anthracis in environments where these amino acids are limiting or absent. It also indicates that InhA1 is important for maximal growth in serum, presumably because B. anthracis cannot break down serum proteins to liberate amino acids in its absence.
DISCUSSION
In this work, we studied a fundamental but underinvestigated question concerning the basic biology of a potentially important arm of the host-pathogen interaction: how pathogenic bacteria like B. anthracis acquire amino acids in a serum-like environment. To facilitate this, we developed a defined medium (BSM) that contains the basic chemical components found in human serum to which we can readily add various additional serum proteins to determine how bacteria overcome amino acid limitation. This work led to the following unique findings: (i) that B. anthracis can use hemoglobin, regardless of its oxidation state, to enhance growth when challenged with a limited amount of valine and methionine, (ii) that the hemoglobin is proteolyzed into small peptides, at least one of which can directly serve as a source of valine, (iii) that the process is iron blind, that is, under conditions where excess iron or heme boosts the growth of the cells in the presence of essential amino acids, in their absence, the driving factor in enhancing growth is the acquisition of amino acids from hemoglobin and not iron, (iv) that at least one secreted protease from B. anthracis, InhA1, is primarily responsible for this phenotype, (v) that other serum proteins, including serum albumin, may also serve as a source of amino acids, while immunoglobulin does not, (vi) and that these findings can be recapitulated in cell-free serum, thereby justifying the practical use of BSM to experiment along these lines.
Why would B. anthracis proteolyze serum proteins? There may be several good reasons for this, including as a mechanism to enhance virulence. However, one must keep in mind the life cycle of B. anthracis and how maximizing replication in the blood of an infected host can really benefit the bacterium. Since the mode of transmission is via a spore, it makes evolutionary sense to make as many vegetative cells as possible to maximize the number of spores that are made. Since the work with BSM suggests that the bacilli do not have as many amino acids as they would like, it would be a benefit to attain more amino acids through other sources. Additionally, studies suggest that the host can restrict specific amino acids during infection, limiting their availability to pathogens (7, 43, 44) . We view the degradation of host proteins to be a way to overcome nutrient limitation, since the production of more spores may increase the chances of initiating more rounds of infection.
Bacterial proteases are well-studied virulence factors that disrupt critical host processes and directly engage the host, and three main functions of bacterial proteases can be delineated. First, some extracellular bacterial proteases disable components of the host's acquired or innate immune system. These include the IgA proteases, produced by Neisseria gonorrhoeae and Haemophilus influenzae species, which may facilitate the colonization of mucosal surfaces (45) (46) (47) . The fact that murine IgG was unable to be cleaved in the presence of B. anthracis is likely indicative of the protein's resistance to many bacterial proteases (48) . A second function of secreted bacterial proteases, particularly of the socalled collagenolytic proteases, is the degradation of the various collagens present in human or animal tissues (49) . These may function to eliminate tissue barriers to promote the invasion or spread of bacterial pathogens. Third, bacterial proteases target several serum factors to alter the clotting of blood. This includes S. pyogenes exotoxin B (SpeB), also called streptopain, a cysteine protease that binds plasminogen and plasmin and cleaves fibrinogen (50) . Finally, bacterial proteases are important in the pathogenesis of periodontal disease, highlighted by a fourth utility by bacterial proteases: the liberation of critical nutrients. Studies have demonstrated the Porphyromonas gingivalis-dependent degradation of hemoglobin (51) , an activity linked to the activity of a lysine-specific protease K-gingipain (Kgp) (52). Since P. gingivalis can grow on hemoglobin under iron-limiting conditions (53) , possibly through the release of heme and subsequent capture by the secreted hemophore HmuY (54), the proteolysis of hemoglobin represents one possible way to satisfy this pathogen's need for iron. Considering that two other periodontal bacterial pathogens (Prevotella nigrescens and Prevotella intermedia) also degrade hemoglobin to liberate heme (55) and that P. intermedia makes a protein termed interpain (InpA) that degrades methemoglobin (56) , the proteolytic processing of hemoglobin to liberate heme represents one way to overcome iron nutritional immunity during infection.
However, in these cases, it seems that the proteolysis of hemoglobin is meant to release heme for iron uptake. We propose adding a new function to the growing list of functions of secreted bacterial proteases, one in which their activity not only can disable the innate immune system or destroy barriers but also can liberate a wide range of previously sequestered and inaccessible life-sustaining nutrients, such as essential amino acids. How widespread this property is in other blood-borne bacterial pathogens remains to be determined, although preliminary data suggest that Bacillus cereus, a cousin of B. anthracis, also exhibits hemoglobin-dependent growth when amino acid concentrations are limiting (data not shown). This nutrient acquisition tactic might represent the need of sporulating bacteria to generate many vegetative cells as quickly as possible before the conditions change to favor sporulation. Since the spread and replication of this pathogen are enhanced through spore contamination of soil, this might be a strategy to increase spore numbers to increase the chance of another infection in a different host. Such a lifestyle is not true for pathogens like Staphylococcus aureus and Escherichia coli, which are unable to perform hemoglobin-dependent growth under the same conditions (data not shown).
B. anthracis, like many bacterial pathogens, secretes an assortment of proteases (see Table S3 in the supplemental material) (9) . There is strong evidence that proteases contribute substantially to anthrax as well, and the InhA1 protease, which is suggested from the findings of the present study to degrade hemoglobin, is involved in a number of pathogenic properties for Bacillus species. Popov and colleagues (57) found that protease inhibitors showed a synergistic protective effect when administered with antibiotics in mice given a lethal dose of B. anthracis, suggesting that proteolytic activity contributes to the onset of anthrax. Indeed, mice infected with a B. anthracis strain lacking inhA1 survived longer than their wild-type-infected counterparts, a property potentially related to the fact that many fewer bacilli penetrate the bloodbrain barrier and infect the brain (58) . The beneficial action of InhA1 does not apply just to B. anthracis; the homolog of this protease from Bacillus thuringiensis (an insect pathogen) and B. cereus (a cause of food poisoning) is necessary for efficient escape from macrophages (59) .
Of note here is what happens to serum protein peptides that are generated by secreted proteases, such as InhA1. Hemoglobin-derived peptides are likely fated to undergo processing by multiple peptidases and are transported via di-/tripeptide and oligopeptide permeases located on the cell surface. Interestingly, the B. anthracis genome appears to contain several gene clusters whose organi- (Left) The traditional view that hemoglobin serves as a source of iron via its bound heme cofactor. Indeed, B. anthracis secretes hemophores to extract heme from hemoglobin and transfer the liberated heme to covalently anchored surface proteins of the Isd-like system, which eventually import the heme into the cell. RBC, red blood cell. (Right) Here, we report another independent use of iron, whereby secreted proteases of B. anthracis process hemoglobin and other serum proteins into small peptides. These peptides are likely transported by a membrane-bound Opp permease and further processed by cytosolic peptidases to enhance the growth of this pathogen by providing essential amino acids, such as valine or methionine.
zation is similar to that of the operons of the oligopeptide permease (Opp) transport systems in B. thuringiensis and B. subtilis that are characterized as being important for virulence and sporulation, respectively (60, 61) . It is plausible that peptides generated from the InhA1 proteolysis of hemoglobin are transported through these permeases and catabolized by amino-and carboxypeptidases to liberate singular, free amino acids for consumption.
The data presented here suggest that we should rethink how we view hemoglobin in terms of utility to bacterial pathogens. We propose that during infection, B. anthracis secretes anthrolysin O, leading to the lysis of red blood cells (62) . The released hemoglobin might serve as a source of two essential nutrients. First, under conditions of low iron, secreted hemophores harboring near-iron transporter (NEAT) domains work to actively extract heme from free hemoglobin, thereby helping satiate a need for iron (63) (64) (65) . Second, we propose that the InhA1 secreted by B. anthracis could efficiently cleave hemoglobin, releasing peptides (Fig. 6) . B. anthracis uses the peptides to acquire limiting amino acids (in the absence of de novo synthesis), thereby maximizing the growth of the bacteria as the disease progresses. Additional proteolytic activity induces coagulation and tissue destruction, thereby releasing more nutrients, breaking barriers to further dissemination, and crippling the host's ability to maintain homeostasis. The result is an all-out feeding frenzy, maximizing access to nutrients to make as many progeny as possible before conditions change to direct sporulation. The development of a suitable small-animal infection system to test this model would go far in determining how some very important bacterial pathogens sustain the high levels of replication often needed to overwhelm their vertebrate hosts.
